SCHEMBL4297147

SCHEMBL4297147

Cc1ccc2cc(S(=O)(=O)O)cc(S(=O)(=O)O)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.49
ALDH1A1 P00352 5/20 0.49
CASP6 P55212 4/20 0.49
CYP2C9 P11712 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CYP2C19 P33261 1/20 0.49
NSD2 O96028 3/20 0.46
NT5E P21589 2/20 0.46
CYP1A2 P05177 2/20 0.46
PTGES O14684 1/20 0.44
ENPP2 Q13822 1/20 0.44
HIF1A Q16665 1/20 0.44
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
DUSP3 P51452 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12521292 0.90 SNCA (0.44) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL8469484 0.88 ALDH1A1 (0.52) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL12807708 0.86 SNCA (0.49) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL4297142 0.84 NT5E (0.66) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL10600636 0.84 CYP2A6 (0.43) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL5292706 0.83 CASP6 (0.68) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL31398448 0.83 CASP6 (0.68) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL31398449 0.83 CASP6 (0.68) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL392126 0.83 CASP6 (0.68) SNCAALDH1A1CASP6CYP2C9HSD17B10
SCHEMBL13744667 0.82 SNCA (0.38) SNCAALDH1A1CASP6CYP2C9HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023189399-A1 POLYMER AND USE THEREOF 日産化学株式会社 2023-10-05 WO disclosed
WO-2023007147-A1 6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES THE UNIVERSITY OF MANCHESTER (GB) 2023-02-02 WO disclosed
WO-2020218316-A1 METHOD FOR PRODUCING ARYLSULFONIC ACID ESTER COMPOUND 日産化学株式会社 2020-10-29 WO disclosed
US-10177315-B2 Arylsulfonic acid compound, use thereof, and method for producing arylsulfonic acid compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2019-01-08 US disclosed
EP-1716211-B1 CONCENTRATED AQUEOUS COMPOSITIONS OF DYESTUFFS ARCHROMA IP GMBH (CH) 2018-02-28 EP disclosed
US-20160248018-A1 ARYLSULFONIC ACID COMPOUND, USE THEREOF, AND METHOD FOR PRODUCING ARYLSULFONIC ACID COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-08-25 US disclosed
US-20160248018-A1 ARYLSULFONIC ACID COMPOUND, USE THEREOF, AND METHOD FOR PRODUCING ARYLSULFONIC ACID COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-08-25 US disclosed
EP-3056484-A1 ARYLSULFONIC ACID COMPOUND, USE THEREOF, AND METHOD FOR PRODUCING ARYLSULFONIC ACID COMPOUND Nissan Chemical Industries, Ltd. (JP) 2016-08-17 EP disclosed
EP-2633087-B1 NON-METAL TANNING PROCESS STAHL INT BV (NL) 2014-09-17 EP disclosed
US-8834619-B2 Ink composition, ink for inkjet recording and inkjet recording method FUJIFILM CORPORATION (JP) 2014-09-16 US disclosed
US-7279033-B2 Ink jet and ink jet recording method FUJIFILM CORPORATION (JP) 2007-10-09 US disclosed
US-7250079-B2 Coloring composition and inkjet recording method FUJIFILM CORPORATION (JP) 2007-07-31 US disclosed
US-7220302-B2 Ink and ink set for inkjet, and inkjet recording method FUJIFILM CORPORATION (JP) 2007-05-22 US disclosed
US-20070109376-A1 Ink composition, ink set and recording method FUJIFILM CORPORATION 2007-05-17 US disclosed
US-20070101899-A1 Black ink and ink set for inkjet recording FUJI PHOTO FILM CO., LTD. (JP) 2007-05-10 US disclosed
US-20070101515-A1 Concentrated aqueous compositions of dyestuffs ARCHROMA IP GMBH (CH) 2007-05-10 US disclosed
US-20070070159-A1 Ink composition, ink set and recording method FUJI PHOTO FILM CO., LTD. 2007-03-29 US disclosed
EP-1525267-B1 ANIONIC MONOAZO DYES CIBA SC HOLDING AG (CH) 2007-03-21 EP disclosed
US-7192475-B2 colored materials having good hue, excellent fastness to light and active gases in the circumstance, particularly an ozone gas, and high printing density FUJI PHOTO FILM CO., LTD. (JP) 2007-03-20 US disclosed
US-20070052783-A1 Ink for inkjet printing ink set for inkjet printing inkjet recording material and producing method for inkjet recording material and inkjet recording method FUJIFILM CORPORATION (JP) 2007-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160248018-A1 ARYLSULFONIC ACID COMPOUND, USE THEREOF, AND METHOD FOR PRODUCING ARYLSULFONIC ACID COMPOUND ARSA, SULT2A1, SULT1A1 SNCA 2001/4885ALDH1A1 132/4885CASP6 2251/4885
US-10177315-B2 Arylsulfonic acid compound, use thereof, and method for producing arylsulfonic acid compound ARSA, SULT2A1, SULT1A1 SNCA 2001/4885ALDH1A1 132/4885CASP6 2251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.